Predicting improvements in survival based on improvements in pathologic response rate to neoadjuvant chemotherapy in different breast cancer subtypes

被引：1
|
作者：
Hatzis, C.
Gould, R. E.
Zhang, Y.
Abu-Khalaf, M.
Chung, G.
Sanft, T.
Hofstatter, E.
DiGiovanna, M.
Shi, W.
Chagpar, A.
Symmans, W. F.
Pusztai, L.
机构：
[1] Yale Univ, Ctr Canc, New Haven, CT USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Yale Univ, New Haven, CT 06520 USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P6-06-37
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-06-37
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Molecular analysis in breast cancer subtypes and correlation with pathologic complete response (pCR) to neoadjuvant chemotherapy.
    Gonzalez Cao, Maria
    Costa, Carlota
    Angel Molina-Vila, Miguel
    Teresa Cusido, Maria
    Viteri Ramirez, Santiago
    Baulies, Sonia
    Martinez-Bueno, Alejandro
    Fabregas, Rafael
    Tresserra, Francesc
    Sansano, Irene
    Ara, Carmen
    Amselen, David
    Ubeda, Belen
    Simo-Perdigo, Marc
    Gasco, Amaya
    Rodriguez, Ignacio
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival
    Melisko, Michelle E.
    Moore, Dan H.
    Sneed, Penny K.
    De Franco, Julia
    Rugo, Hope S.
    JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (03) : 359 - 365
  • [23] Gene expression and pathologic response to neoadjuvant chemotherapy in breast cancer
    Kolacinska, Agnieszka
    Fendler, Wojciech
    Szemraj, Janusz
    Szymanska, Bozena
    Borowska-Garganisz, Ewa
    Nowik, Magdalena
    Chalubinska, Justyna
    Kubiak, Robert
    Pawlowska, Zofia
    Blasinska-Morawiec, Maria
    Potemski, Piotr
    Jeziorski, Arkadiusz
    Morawiec, Zbigniew
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (07) : 7435 - 7441
  • [24] Progress in Evaluation of Pathologic Response to Neoadjuvant Chemotherapy of Breast Cancer
    Gebreamlak, Estifanos P.
    Tse, Gary M. K.
    Niu, Yun
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (02) : 222 - 226
  • [25] Gene expression and pathologic response to neoadjuvant chemotherapy in breast cancer
    Agnieszka Kolacinska
    Wojciech Fendler
    Janusz Szemraj
    Bozena Szymanska
    Ewa Borowska-Garganisz
    Magdalena Nowik
    Justyna Chalubinska
    Robert Kubiak
    Zofia Pawlowska
    Maria Blasinska-Morawiec
    Piotr Potemski
    Arkadiusz Jeziorski
    Zbigniew Morawiec
    Molecular Biology Reports, 2012, 39 : 7435 - 7441
  • [26] Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival
    Michelle E. Melisko
    Dan H. Moore
    Penny K. Sneed
    Julia De Franco
    Hope S. Rugo
    Journal of Neuro-Oncology, 2008, 88 : 359 - 365
  • [27] Survival and recurrence of breast cancer patients with pathologic complete response after neoadjuvant chemotherapy.
    Lee, Young Joo
    Ahn, Sei-Hyun
    Sohn, Byung Ho
    Lee, Jong Won
    Chung, Il Yong
    Ko, Beom Seok
    Kim, Hee Jeong
    Kim, Jisun
    Lee, Sae Byul
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] PREDICTIVE SIGNIFICANCE OF BREAST CANCER SUBTYPES IN RESPONSE TO NEOADJUVANT CHEMOTHERAPY
    Kobayashi, N.
    Kiriyama, Y.
    Hikichi, M.
    Miyajima, S.
    Kuroda, M.
    Utsumi, T.
    BREAST, 2013, 22 : S103 - S103
  • [29] Predictors of response to neoadjuvant chemotherapy: Importance of breast cancer subtypes
    Sharma, Mukesh
    Revannasiddaiah, Swaroop
    Negi, Muninder
    Negi, Ratti Ram
    CLINICAL CANCER INVESTIGATION JOURNAL, 2015, 4 (03): : 479 - 480
  • [30] Prognostic implications of response to neoadjuvant chemotherapy in breast cancer subtypes
    Yildiz, Anil
    Bilici, Ahmet
    Acikgoz, Ozgur
    Hamdard, Jamshid
    Basim, Pelin
    Cakir, Tansel
    Cakir, Asli
    Olmez, Omer Fatih
    Gezen, Cem
    Yildiz, Ozcan
    JOURNAL OF CHEMOTHERAPY, 2025, 37 (01) : 60 - 68
12345